Posts tagged as:

Risperdal

Tweet- From LexisNexis® Mealey’s™ Daily Legal News An Arkansas state court judge on Jan. 31 ordered Johnson & Johnson to pay $ 181.1 million to a law firm that last year got the state government a record $ 1.2 billion verdict for alleged violations of state law in the marketing of the atypical antipsychotic drug […]

{ 0 comments }

TweetJohnson & Johnson on Oct. 3 agreed to settle five Pennsylvania state court cases in which plaintiffs allege that the atypical antipsychotic drug Risperdal caused adolescent boys to develop enlarged breasts, plaintiffs’ counsel told Mealey Publications (A.B., et al. v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 100100649, S.B., et al. v. Janssen Pharmaceuticals, Inc., May Term 2010 No. […]

{ 0 comments }